Incidence Rate of Tuberculosis Among Individuals With HIV in Africa Higher Than Estimated
Dr Ryan Haumschild Discusses Payer, Provider Perspectives on Prior Authorization in Rare Diseases
What We’re Reading: Health Programs Threatened; Midwives Needed; Sleep Deprivation and Screen Time
Dr Michael Petrosky Speaks About Monoclonal Antibodies in RSV
COVID-19 Pandemic Affected Consistency of Care for Patients With PAH, Study Finds
Relative Benefit in Survival, Reduction in TE/MAVE Risk With Eculizumab for Patients With PNH
NCCN Working Group Presents Health-Related Social Needs Recommendations at Policy Summit
Dr Kristine Slam: Value-Based Care in Breast Cancer Requires Collaboration
HR+ NSCLC More Common in Women; EGFR, KRAS More Common in HR+ NSCLC
Vikki Walton, MBA, Shares How Employers Can Improve Health Equity
Since FDA Approval, Several Studies Highlight Benefits of IV Ferric Carboxymaltose
Prevalence, Incidence of Early-Onset CRC Increased in Individuals Aged 40 to 49 Years
Dr Tariq Cheema Discusses Patient, Family Experiences With Virtual ICU Care
Sports Medicine Doctors: Managing Care Beyond the Pitch
Differences in Ophthalmology Residents’ Medical Knowledge Ratings Could Indicate Gender Disparities
What We’re Reading: Mental Health AI Tools; Obesity Drug Shortages; Health Worker Mask Guidelines
PTSD Symptom Screening Important for Those With Insomnia, Especially Women
Part 2: Certain Patients Could Benefit From High-Sodium Medications, Says Dr Michael Thorpy
Flow Cytometry, Cytomorphological Features Correlate With MDS Prognosis
OneOncology and Its Practice Partners Celebrate 5 Years of Cancer Care Excellence
Contributor: Medicare’s Leadership Needs to Confront Our Shrinking US Workforce
Dr Susan Spratt Discusses Diabetes Management Services at Duke Health
Atopic Dermatitis, Systemic Inflammation Not Linked to Dementia Risk
Dr Monica Taylor-Desir on Taking Mental Health Care Awareness to Action
Diet and Exercise Intervention Associated With Better pCR in TNBC or HR+, HER2– BC
Switching Back to Originator From Biosimilar Infliximab Results in Higher Discontinue Rates
FDA Approves Momelotinib for Myelofibrosis With Anemia
Novel PET-Based Radiomics Signature Predicts CAR T Efficacy in DLBCL
PASS “Yes” Status in MG Potentially Achievable 2 Years After Diagnosis
Late-Stage Trial in Chronic Hepatitis D Discontinued Due to Safety Concerns